In today’s blog, it is our pleasure to introduce you to Guillaume Hagège, Vice President of Portfolio & Alliance Management.
Hi Guillaume, Can you tell us what is your role at SparingVision?
As Head of Portfolio management, I coordinate the company’s programs and support strategic planning by aligning priorities, driving execution and exploring external opportunities.
What inspired you to join the genomic medicine in ophthalmic industry, and what keeps you motivated?
Genomic medicine has the potential to transform healthcare. In ophthalmology, preserving or restoring vision has a clear, life-changing effect – that’s what motivated me to join SparingVision and continues to drive me.
How do you work with different teams across the company (and/or outside)?
My role is naturally cross-functional: I work across teams to keep programs aligned and on track, ensuring clear priorities and coordination. I also engage with external partners, especially when exploring new opportunities or collaborations.
We always say everything at SparingVision starts with the patient. What does that mean in your role?
Every decision — timelines, resources, or new opportunities — needs to consider the impact on patients. Our strategy isn’t just about advancing science but about ensuring we ultimately deliver real solutions to those who need them most.
